Armando Anido
2021
In 2021, Armando Anido earned a total compensation of $2.2M as Chairman of the Board and CEO at Zynerba Pharmaceuticals, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $379,675 |
|---|---|
| Option Awards | $446,472 |
| Salary | $603,000 |
| Stock Awards | $772,643 |
| Other | $10,685 |
| Total | $2,212,475 |
Anido received $772.6K in stock awards, accounting for 35% of the total pay in 2021.
Anido also received $379.7K in non-equity incentive plan, $446.5K in option awards, $603K in salary and $10.7K in other compensation.
Rankings
In 2021, Armando Anido's compensation ranked 5,662nd out of 12,415 executives tracked by ExecPay. In other words, Anido earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,662 out of 12,415 | 54th |
Division Manufacturing | 2,399 out of 5,508 | 56th |
Major group Chemicals And Allied Products | 1,044 out of 2,378 | 56th |
Industry group Drugs | 932 out of 2,099 | 56th |
Industry Pharmaceutical Preparations | 671 out of 1,549 | 57th |
Source: SEC filing on April 25, 2022.
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2021.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019